528 related articles for article (PubMed ID: 8845057)
1. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM
J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
[TBL] [Abstract][Full Text] [Related]
2. Response of CD4+ T cells from myasthenic patients and healthy subjects of biosynthetic and synthetic sequences of the nicotinic acetylcholine receptor.
Diethelm-Okita B; Wells GB; Kuryatov A; Okita D; Howard J; Lindstrom JM; Conti-Fine BM
J Autoimmun; 1998 Apr; 11(2):191-203. PubMed ID: 9650099
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis. T epitopes on the delta subunit of human muscle acetylcholine receptor.
Protti MP; Manfredi AA; Wu XD; Moiola L; Howard JF; Conti-Tronconi BM
J Immunol; 1991 Apr; 146(7):2253-61. PubMed ID: 1706391
[TBL] [Abstract][Full Text] [Related]
4. Cryptic epitopes on the nicotinic acetylcholine receptor are recognized by autoreactive CD4+ cells.
Bellone M; Ostlie N; Karachunski P; Manfredi AA; Conti-Tronconi BM
J Immunol; 1993 Jul; 151(2):1025-38. PubMed ID: 7687612
[TBL] [Abstract][Full Text] [Related]
5. Universal epitopes for human CD4+ cells on tetanus and diphtheria toxins.
Diethelm-Okita BM; Okita DK; Banaszak L; Conti-Fine BM
J Infect Dis; 2000 Mar; 181(3):1001-9. PubMed ID: 10720523
[TBL] [Abstract][Full Text] [Related]
6. TCR vbeta usage of TSH receptor-specific CD4+ T cells in Graves' disease patients and healthy humans.
Raju R; Navaneetham D; Kellermann SA; Freeman SL; Morris JC; McCormick DJ; Conti-Fine BM
J Autoimmun; 1997 Oct; 10(5):479-89. PubMed ID: 9376076
[TBL] [Abstract][Full Text] [Related]
7. TCR V beta usage by acetylcholine receptor-specific CD4+ T cells in myasthenia gravis.
Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
J Autoimmun; 1997 Apr; 10(2):203-17. PubMed ID: 9185882
[TBL] [Abstract][Full Text] [Related]
8. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
9. Mapping the major human T helper epitopes of tetanus toxin. The emerging picture.
Reece JC; Geysen HM; Rodda SJ
J Immunol; 1993 Dec; 151(11):6175-84. PubMed ID: 7504014
[TBL] [Abstract][Full Text] [Related]
10. Epitopes for human CD4+ cells on diphtheria toxin: structural features of sequence segments forming epitopes recognized by most subjects.
Raju R; Navaneetham D; Okita D; Diethelm-Okita B; McCormick D; Conti-Fine BM
Eur J Immunol; 1995 Dec; 25(12):3207-14. PubMed ID: 8566002
[TBL] [Abstract][Full Text] [Related]
11. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
[TBL] [Abstract][Full Text] [Related]
12. TSH receptor sequences recognized by CD4+ T cells in Graves' disease patients and healthy controls.
Kellermann SA; McCormick DJ; Freeman SL; Morris JC; Conti-Fine BM
J Autoimmun; 1995 Oct; 8(5):685-98. PubMed ID: 8579724
[TBL] [Abstract][Full Text] [Related]
13. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.
Demotz S; Barbey C; Corradin G; Amoroso A; Lanzavecchia A
Eur J Immunol; 1993 Feb; 23(2):425-32. PubMed ID: 7679644
[TBL] [Abstract][Full Text] [Related]
14. Tetramer-guided epitope mapping reveals broad, individualized repertoires of tetanus toxin-specific CD4+ T cells and suggests HLA-based differences in epitope recognition.
James EA; Bui J; Berger D; Huston L; Roti M; Kwok WW
Int Immunol; 2007 Nov; 19(11):1291-301. PubMed ID: 17906339
[TBL] [Abstract][Full Text] [Related]
15. Identification of two promiscuous T cell epitopes from tetanus toxin.
Ho PC; Mutch DA; Winkel KD; Saul AJ; Jones GL; Doran TJ; Rzepczyk CM
Eur J Immunol; 1990 Mar; 20(3):477-83. PubMed ID: 1690656
[TBL] [Abstract][Full Text] [Related]
16. Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients.
Protti MP; Manfredi AA; Straub C; Wu XD; Howard JF; Conti-Tronconi BM
J Immunol; 1990 Mar; 144(5):1711-20. PubMed ID: 1968487
[TBL] [Abstract][Full Text] [Related]
17. Delineation of several DR-restricted tetanus toxin T cell epitopes.
Demotz S; Lanzavecchia A; Eisel U; Niemann H; Widmann C; Corradin G
J Immunol; 1989 Jan; 142(2):394-402. PubMed ID: 2463305
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing.
de Koster HS; van Rood JJ; Termijtelen A
Eur J Immunol; 1992 Jun; 22(6):1531-9. PubMed ID: 1376262
[TBL] [Abstract][Full Text] [Related]
19. Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone.
Saruhan-Direskeneli G; Weber F; Meinl E; Pette M; Giegerich G; Hinkkanen A; Epplen JT; Hohlfeld R; Wekerle H
Eur J Immunol; 1993 Feb; 23(2):530-6. PubMed ID: 7679649
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory CD8+ cells recognize antigen-activated CD4+ cells in myasthenia gravis patients and in healthy controls.
Yuen MH; Protti MP; Diethelm-Okita B; Moiola L; Howard JF; Conti-Fine BM
J Immunol; 1995 Feb; 154(3):1508-20. PubMed ID: 7529806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
